Entero Therapeutics, Inc.
Entero Therapeutics, Inc. (ENTO) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
ENTO · net income · updated Jun 9, 2026
Core profitability metrics
ENTO · net income · margin · TTM · CAGRNet income was −$6.6M for FY2025 (fiscal year ending 2025-12-31), up 63.7% year-over-year. Net profit margin was -18078.3%.
Annual net income history
▸ FMP /income-statement · Annual · ENTO net income history · ENTO profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Entero Therapeutics, Inc. (ENTO) reported net income of −$6.6M for FY2025 (fiscal year ending 2025-12-31), up 63.7% year-over-year. The net profit margin was -18078.3% — meaning the company kept $-180.78 of every dollar of revenue as profit.
Entero Therapeutics, Inc. has not yet achieved annual profitability based on available data (13 fiscal years). The company has reported net losses across all available periods.
Entero Therapeutics, Inc.'s net profit margin was -18078.3% for FY2025, based on the latest annual results.
Investors sometimes search for "Entero Therapeutics, Inc. net worth" — the company's market capitalization is a separate figure from ENTO net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
ENTO net income · 4 questionsEntero Therapeutics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $6.6M for FY2025.
▸ Source: FMP /income-statement · GAAP · Entero Therapeutics, Inc. · Entero Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026